


International non-profit developing safe, effective, and affordable treatments for the most neglected patients. bsky.app/profile/dndi.org


Generating drug-resistant parasites helps us understand how a drug normally kills them, but this isn’t always easy. See how the problem was solved for a promising series of antileishmanial compounds in a study in @NatureComms. nature.com/articles/s41467-0…

Whipworm remains one of the hardest intestinal worm infections to treat. This Phase 2a trial in Tanzania found that while single doses of oxfendazole offered little benefit, a 3-day course showed promising efficacy and was well tolerated. @eClinicalMed thelancet.com/journals/eclin…

Progress against neglected diseases depends on strong partnerships. This study highlights the role of the Chagas Platform and RedeLEISH in strengthening research capacity through collaboration, shared goals, and knowledge transfer. doi.org/10.1590/S0103-733120…

How do we develop treatments for diseases like dengue when outbreaks are unpredictable? This paper in @OFIDJournal from the Dengue Alliance & partners propose more flexible clinical trial approaches to speed up therapeutic development. academic.oup.com/ofid/articl…

How did we get from a toxic treatment to a single-dose cure for sleeping sickness? Our latest film 'The Road to One Dose’ tells the story of the early science & collaborations behind acoziborole, a new oral treatment designed to be taken in one dose. youtu.be/x5D3QLD_MtQ

Scientific innovation alone is not enough. Researchers are partnering with communities to design and develop trusted, transformative #GlobalHealth solutions. Learn more from @MedsforMalaria, @DNDi, @ImpSanteAfrique, & University Clinical Research Centre! bit.ly/48hGE25

On 16 November, the @EU_Commission, @EUinJapan, @MHLWitter, #SCARDA and @DNDi met in Tokyo to discuss international R&D cooperation against infectious disease threats, with dengue as a case study. 👉 link.europa.eu/WcVnMR

Across Africa, communities, healthcare workers, researchers, implementing partners and funders are working together to improve access to life-saving advanced HIV disease care. IMPAACT4HIV brings these voices and efforts together around a shared goal: strengthening access to diagnosis, treatment and care for people living with advanced HIV disease. Watch the video to hear from the people and partners contributing to this work across countries and explore the stories and resources behind the AHD response. youtube.com/watch?v=TVyylLLe… Explore the IMPAACT4HIV/Advanced HIV Hub: advancedhivhub.org/ #AdvancedHIVDisease #AHD #CommunityEngagement #AccessToCare #EndAIDS @UNITAID @MarktAccessAfri @OSolthis @cihp_ng @DNDi @teampata

Climate-sensitive infectious diseases must be a priority for climate adaptation. In a joint policy brief, MMV & partners outline 5 priorities for strengthening prevention, diagnosis and treatment through climate and health policies, plans and financing: bit.ly/4sUjZlP

Communities are essential to delivering medical interventions. Their lived experiences should also inform how new innovations are developed. In a joint op-ed, global health experts explore why community engagement must begin earlier in health research: bit.ly/4iSMYly

Geneva is full of people working on global health, which made the Geneva Health Forum 2026 a great place for GARDP to be. We brought two posters: 🔬 The AMR brain drain, and how REVIVE can help the antimicrobial R&D community stay connected and share knowledge. 💊 The @DNDi-GARDP CMC platform, developed with DNDi, showing how shared specialist capabilities can make product development stronger and create more sustainable routes to new medicines. We also joined a participatory roundtable on strengthening synergies with health product development partners in Geneva, looking at how PDPs, universities, research institutions, start-ups and companies can work together more effectively. The conversation continues in 2027 with two follow-up seminars, aimed at turning these connections into real opportunities to collaborate. Developing the next health innovation is only part of the challenge. It also takes the expertise, capabilities and partnerships to get promising ideas to the people who need them. #GenevaHealthForum #GlobalHealth #AMR #GARDP #REVIVE

Medicamentos para DTNs avançam entre desafios de financiamento, avaliação de cura e acesso sbmt.org.br/medicamentos-par…


Will you be at #ASTMH2026? 👋 Join us on 19 Nov to discover our 2027–2031 Strategic Plan and exchange with our disease heads and R&D experts on leishmaniasis, dengue, pandemic preparedness, Chagas, and fungal diseases. 👉 Register here: eventbrite.com/e/dndi-new-st… @ASTMH

📣 Just a few days left to apply! We’re partnering with @MSF_SouthAsia to invite journalists, photographers, filmmakers, influencers, and editors from across South Asia to apply for our media fellowship. Find out more and apply here: dndi.org/press/media-worksho… #MediaFellowship